Skip to main content

Table 4 Prediction for length of stay using medical records and claims data-based comorbidity index score

From: A comparison of the Charlson comorbidity index derived from medical records and claims data from patients undergoing lung cancer surgery in Korea: a population-based investigation

  

Exp[coefficient] based on medical records

95% Confidence interval

Exp[coefficient] based on claims data

95% Confidence interval

Age[years]

≤ 49

1

 

1

 
 

50-59

1.06

(0.880-1.295)

1.06

(0.871-1.282)

 

60-69

1.2

(1.000-1.448)

1.19

(0.986-1.427)

 

≥ 70

1.07

(0.866-1.328)

1.05

(0.846-1.305)

Gender

male

1

 

1

 
 

female

0.96

(0.832-1.113)

0.96

(0.833-1.116)

Histologic subtype

squamous cell carcinoma

1

 

1

 
 

adenocarcinoma

0.95

(0.834-1.094)

0.96

(0.839-1.101)

 

bronchoalveolar carcinoma

1.1

(0.827-1.471)

1.1

(0.827-1.473)

 

large cell carcinoma

0.79

(0.372-1.675)

0.8

(0.377-1.709)

 

small cell carcinoma

1.21

(0.654-2.268)

1.19

(0.640-2.227)

 

other

0.94

(0.552-1.626)

0.96

(0.558-1.639)

Surgical treatment type

wedge resection

1

 

1

 
 

lobectomy

1.15

(0.832-1.607)

1.18

(0.851-1.641)

 

pneumonectomy

0.98

(0.674-1.438)

1.01

(0.688-1.469)

 

other

1.43

(0.721-2.864)

1.46

(0.729-2.913)

Pathologic stage

I

1

 

1

 
 

II

0.96

(0.832-1.123)

0.97

(0.838-1.132)

 

III

1.13

(0.993-1.302)

1.15*

(1.005-1.314)

CCI score

0

1

 

1

 
 

1

0.92

(0.809-1.062)

0.99

(0.863-1.128)

 

2+

0.94

(0.775-1.144)

1

(0.872-1.142)

  1. *p < 0.05 according to multiple linear regression analysis using log-transformed length of stay